Alarm bells raises questions

I'm no expert but in my opinion the 2016 half-year results ring some alarm bells for me and raise a few questions in my mind.
1. Steep negative trend of half-yearly NPAT over the last 5 half-years!
2. Revenue in essence flat so why the substantial increases in debtors, inventory, creditors & short term
borrowings resulting in Quick ratio/acid test approaching 1?
3. Inventory level is at least 6 months COGS. How much redundant parts and old products is included in
this that will have to be written off as part of product rationalization?
4. Closing manufacturing in Perth. Will Medicom continue to be manufactured in the US... or only Tecera?
And how will this affect Australian revenues which is still the highest and most (only) profitable region
(positive $1,177k NPAT)?

JazzMan